The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
LDDD · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | TER | UTMD | LDDD | AME |
|---|---|---|---|---|
| Moat Score (0–100) | 76 | 77 (highest) | 76 | 76 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 23 | 23 | 70 | 95 (highest) |
| Pricing power | 97 | 100 (highest) | 91 | 60 |
| Returns on capital | 97 | 100 (highest) | — | 54 |
| Balance-sheet safety | 100 (highest) | 100 (highest) | 100 (highest) | 89 |
| Capital discipline | 64 | 63 | 44 | 80 (highest) |
| Price vs. high estimate | 787% above high estimate | 11% below high estimate (largest discount to high estimate) | No price data | 103% above high estimate |
| Market cap | $54.6B | $214M | $15.3M | $55.4B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |